Policy analysis highlights efforts to safeguard clinical research in the U.S., ensuring access to new therapies for patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
C&EN editorial team (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: